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CAN LIFE BE STANDARDIZED?
Current challenges in biological standardization
JuLi Peretó and ManueL Porcar
The concept of standard strongly evokes machines, industries, electric or mechanical devices, 
vehicles, or furniture. Indeed, our technological civilization would not be possible – at least in the 
terms it is structured today – without universal, reliable components, whose acknowledged use 
results in competitive costs, robustness and interchangeability. For example, an Ikea screw can 
be used in a wide set of structurally dissimilar furniture and an app can be run on many different 
smartphones. The very concept of standardization is linked to the industrial revolution and mass 
production of goods through assembly lines. The question we will try to answer in the present 
paper is the extent to which standards and the standardization process can be accomplished in 
the biological realm.
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Synthetic biology, defined as the engineering approach 
to biotechnology, attempts to give a systematic, 
standard-based flavor to genetic engineering. 
The central idea of synthetic biology is to make 
biology easier to engineer by incorporating tools 
and concepts borrowed from (mainly industrial 
and electronic) engineering. Engineering notions 
such as abstraction, decoupling and standardization 
are applied nowadays to the design of biomolecular 
systems. These efforts bring both new insights 
on the molecular intricacies and interactions 
in complex systems (i.e., cells and their 
environmental interactions), 
as well as advances in projects 
addressing a wide diversity 
of issues, from agriculture 
to medicine. Nevertheless, 
many critical challenges arise 
from this engineering approach 
to biotechnology, most of which 
are out of the scope of this 
article. One major issue, though, 
will be discussed in some detail 
in the next sections of this paper: the issue referring 
to some of the specific challenges the standardization 
process poses in the biological realm. The fact that 
both living organisms and machines are subject 
to the laws of physics does not mean that living 
beings are machines (for a recent, exhaustive work 
on the topic, see Nicholson, 2019). The differences 
between evolution-issued and human-made complex 
systems are linked to the difficulties for standardizing 
the former, as we discuss in the following sections.
 ■ PROMISCUITY
Every aspect of life is the outcome of networks 
of interactions between a diversity of components, 
either intracellular molecules, cells in multicellular 
organisms, or species in ecosystems. Thus, 
living beings are complex 
systems – in the same sense 
as physicists use this expression. 
For instance, at the molecular 
level, thousands of small 
molecules, macromolecules, 
and supra-macromolecular 
assemblies drive the ability 
to construct all the cell 
components from external 
feedstocks (i.e., metabolism) 
or the capacity to store and transmit the genetic 
(digital) information that must be decoded to unfold 
cellular functions. Proteins are key macromolecules 
supporting biological activities, and biochemists 
and structural biologists have gathered an impressive 
«The fact that both living 
organisms and machines 
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volume of details about the architecture, dynamics, 
and interactions of these molecular engines. Within 
the context of synthetic biology, proteins are usually 
considered interchangeable parts of the system 
that, through molecular interactions, can perceive 
and process inputs, and elicit 
outputs, as it occurs in any 
information processing system. 
But designed biological 
systems pose several issues that 
may result in a departure from 
the predicted behavior.
When a given protein 
is transplanted to a non-
native context, a diversity 
of unintended interactions may emerge. This 
situation has been referred to as semantic errors 
in a discussion on potential failures in synthetic, 
reconstructed systems (Kittleson et al., 2012). 
For instance, the overproduction of a non-native 
metabolite, such as mevalonic acid, in Escherichia 
coli, results in toxic effects, namely, the inhibition 
of fatty acid biosynthesis by one of the intermediates 
of the heterologous pathway (Kizer et al., 2008). 
In addition to the native function, sculpted by natural 
selection, proteins often show promiscuous activities, 
i.e., unwanted side reactivities or interactions that 
in normal conditions do not represent a particular 
harm to the system or simply are non-adaptive. 
Promiscuous activities 
are responsible for the so-
called underground metabolism 
(D’Ari & Casadesús, 
1998), a collection of side 
or minor reactions, traditionally 
overlooked by biochemists, 
which are the outcome 
of the ability of enzymes 
to process substrates other than 
the canonical ones (Khersonsky & Tawfik, 2010). 
Also, molecular promiscuities have been exploited 
in in vitro evolution of new enzymatic activities, 
or even in new non-natural abilities, e.g., enzymes 
The concept of standardization has traditionally been linked 
to universal and interchangeable elements in mechanical 
or electronic devices, machinery, vehicles, furniture, etc. Is it 
possible to apply the finitude, robustness and universality 
of standards to the world of molecular biology?
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using nonbiological substrates 
or chemical elements (Arnold, 
2019). In nature, promiscuous 
activities also may represent 
a drawback if they generate toxic 
products or inhibitors of essential 
functions. In this sense, there 
is a growing evidence of the 
existence of many, until recently 
unnoticed, metabolic repair systems that efficiently 
mitigate or prevent these problems (De Crécy-Lagard 
et al., 2018).
At present, our fragmentary knowledge about 
promiscuous activities is a serious disadvantage 
for the de novo design of artificial circuits. Merging 
proteins from different evolutionary origins in a non-
native context may result in the accumulation of toxic 
or unwanted intermediaries produced by promiscuous 
activities. In the future, synthetic biology may alleviate 
the challenge of the semantic errors (i.e., unexpected 
and undesirable side effects) with a joint effort 
in developing tools to predict and assay promiscuous 
activities, and in updating the public databases 
of enzymes and proteins. Synthetic biology may also 
enable a complete mapping of the metabolic «dark 
matter» through, for example, the discovery of the 
unknown function of many enzymes coded in the 
genomes (Ellens et al., 2017), which can lead to the 
design of strategies to minimize unwanted activities 
through protein and cellular engineering (e.g., 
the design of artificial supramolecular complexes 
or synthetic compartments that are able to channel 
or store the unwanted metabolites). The final 
outcome of all these efforts should be the accurate 
definition of a standard behavior 
of designer biomolecules 
acting in a non-native context, 
a situation that will render 
more predictive and optimized 
artificial systems. At any 
rate, we must remember that 
proteins are a case of soft 
matter and that promiscuity 
is the unavoidable outcome 
of their intrinsic structural 
flexibility and dynamic behavior. Thus, it is wise 
to contemplate the inevitability of promiscuity of the 
system components as a contingency of any synthetic 
biology project, evaluating its impact on the global 
performance of the designer system.
 ■ NOISE
In addition to the presence of promiscuous 
components, we also have to consider that complex 
biological functions are the result of the joint activity 
of populations of entities, either molecules, cells, 
or tissues. In this sense, the stochastic behavior 
of the individual members of the population has been 
perceived as a potential difficulty for engineering 
biological systems, as well as an inconvenience 
In synthetic biology, proteins are considered interchangeable 
parts of a system that, through molecular interactions, 
can perceive, process, and transmit information. However, 
unexpected interactions can occur in synthetic biological 
systems, such as promiscuous activities (i.e., reactions 
and interactions aside from the main function of the protein) 
that may lead to malfunction of the system. A demonstration 
of how the intrinsic flexibility of proteins reveals functions 
is found in the S protein of SARS-CoV-2 (in the picture): 
the movement of one of its structural domains exposes 
the binding surface to the human ACE2 protein. Therefore, 
one of the goals of synthetic biology must be to discover 
the unknown functions of proteins coded in the different 








«Complex biological functions 
are the result of the joint 
activity of populations 
of entities, either molecules, 
cells, or tissues»
Binding surface 





for standardization. Even within genetically 
homogenous populations of cells, 
the stochastic behavior of individuals 
generates noise. This functional diversity 
is due to the differences and fluctuations 
in the available molecular machineries 
inside each individual cell. Even in the most 
ideal of the conditions, two cells will harbor 
different amounts of RNA polymerases 
(enzymes responsible of copying each gene 
in the corresponding template to be decoded), 
ribosomes (cell factories for protein 
synthesis), regulatory factors (that activate 
or inhibit other processes), and so on. Thus, 
when analyzed at the individual level, cells 
exhibit functional variability (Elowitz et al., 
2002) and this phenomenon is also observed 
in artificially designed systems. For instance, 
one of the works generally considered 
as foundational of synthetic biology, 
namely, the design, simulation, and cellular 
implementation of an oscillatory system 
(the repressilator, Elowitz & Leibler, 2000), 
showed variability at the individual cell level 
due to the stochasticity of gene expression 
processes.
In nature, the effect of noise and of 
stochastic phenomena can be mitigated 
by the system itself, whereas in other cases 
those effects can be used as raw material 
for adaptation. In engineered biological 
systems, both approaches have been verified (see 
Kittleson et al., 2012 and references therein). In fact, 
standard operations of biocomputation (i.e., simple 
logical gates) have been successfully implemented 
in cells during the last two decades (Amos & 
Goñi-Moreno, 2018). Nevertheless, the question 
remains whether more complex operations could 
be implemented within the limits of cells, with 
their intrinsic noisy behaviors. Alternatively, 
several groups have made a virtue out of necessity 
by exploring biological messiness and multicellular 
assemblies to test the usefulness of a diversity 
of approaches like stochastic computation, distributed 
computing, and fuzzy logic. The ultimate frontier 
would be to transcend genetic material as the 
only support for logic circuits and use other levels 
of operation, e.g., metabolic networks, to implement 
more complex tasks (for a comprehensive discussion 
on achievements and challenges in biocomputation 
see Amos & Goñi-Moreno, 2018). In this context, 
we would require a more relaxed definition 
of standards.
SEVA is a repository of standardized plasmids developed at the 
National Center for Biotechnology. In the picture, an interactive 
map from their 3.0 website showing the organization of the 
SEVA vectors. Each plasmid contains three basic modules: 
a cargo or DNA portion (magenta), an origin for the replication 
(yellow), and an antibiotic marker (blue). These plasmids can be 






















There is a parallelism between the variants 
of an industrial model (e.g., a car) and the 
races or strains of animals, plants, or bacteria. 
The economic costs of changing the machinery, 
templates, and designs result in a relatively 
low set of variations of the most popular 
car models – or any other artificial device. 
By contrast, organisms display an amazing 
range of variation in the shape of virtually 
millions of species. For example, the favorite 
microbiological model organism, the bacterium 
Escherichia coli, has itself thousands of different 
strains with important genetic differences 
(Moradigaravand et al., 2018). This leads to the 
basic question on whether all the strains behave 
in the same way from the biotechnological point 
of view. In research carried out in the frame of a 
student competition, the iGEM contest,1 six E. coli 
strains commonly used in molecular biology were 
transformed with a simple device consisting of a 
promoter and reporter gene sequences, that is, 
a simple genetic circuit that yields a measurable 
signal usually as fluorescent light. By measuring 
those signals, it was possible to identify how well 
the circuit worked in a particular bacterial strain. 
Surprisingly, significant differences of expression 
levels were found among all six strains 
in five out of the six constructions (Vilanova 
et al., 2015). In another experiment of the same 
work, an E. coli strain was transformed with 
two almost identical gene circuits, one encoding for a 
red protein, and the other for a green one. Cells with 
the expected phenotype – those being both green 
and red – were in fact red, since the majority of the 
transformed population was either red, green, or lacked 
any fluorescence (Vilanova et al., 2015). These results 
evidence that the huge variation of strains or races 
in living organisms implies a lack of reproducibility 
in the behavior of theoretically «standard» (in the sense 
of «universal») genetic components. The contextual 
sensitivity or the influence of the genetic context 
on the performance of even the simplest designed 
circuit has been recognized as one of the challenges 
in synthetic biology (Kittleson et al., 2012).
The iGEM competition mentioned above 
is a spectacular effort to educate the next generation 
of synthetic biology practitioners. Undergraduate 
students worldwide attend the contest 
and present a synthetic biology project which must be, 
1  International Genetically Engineered Machine Competition, https://igem.
org/
The international iGEM synthetic biology competition is a great 
initiative to educate the next generations of synthetic biology 
researchers. Often, competition winners invent their own models 
instead of using the standards already validated by previous 
works. In the image, the room where teams of students 
from around the world show their projects to the rest during 
the competition. The picture belongs to the 2014 run.
«The huge variation of strains 
or races in living organisms implies 
a lack of reproducibility in the behavior 





at least partially, based on a cloning system called 
«Biobricks™». As a result of the very successful 
iGEM events of the last decade, Biobricks have been 
massively used and they are thus ideal for a meta-
analysis on component reuse in synthetic biology. 
The analysis of the award-winning teams clearly 
shows, though, that most of them tend to develop 
their own «standards» rather than using those already 
available – and thus theoretically validated by previous 
works (Vilanova & Porcar, 2014). This leads us to 
the same ironical conclusion that had previously been 
stressed by the Nobel Prize laureate Murray Gell-
Mann: «A scientist would rather use someone else’s 
toothbrush than another scientist’s nomenclature» 
(Vilanova & Porcar, 2019).
That said, there are other examples of biological 
components which are arising as de facto standards 
in the synthetic biology community. The Standard 
European Vector Architecture (SEVA) platform 
is a series of plasmids specifically designed to be 
used in a range of Gram negative (now also Gram 
positive) species. They have been developed by the 
group of Víctor de Lorenzo at the National Centre 
for Biotechnology (Spanish National Research 
Council) and are provided free of charge; a total 
of 2,019 plasmids have been delivered to 35 countries 
and they have received 88 and 277 citations for the 
SEVA 2.0 and SEVA 1.0 version, respectively 
(the SEVA 3.0 has just been launched, Martínez-
García et al., 2019). This highlights the importance 
of robustness and utility of a biological component 
for it to become accepted as a standard by a 
community of users.
 ■ MODULARITY
The concept of module is linked to that of standard. 
Mechanic devices have easily-recognizable sets 
of parts that are designed to be easily mounted, 
exchanged, or repaired. Modules, in biology, 
are rather obvious when it comes to anatomical 
structures. For example, it is not incorrect to define 
lungs as respiratory modules, muscles as motion, 
engine-like modules; or – in the case of eukaryotic 
cells – to consider mitochondria as internal, energy-
producing modules. Indeed, endosymbionts are one 
of the best examples of modules in biological systems 
(Porcar et al., 2013). However, when we move 
all those well-defined and physically-contained 
structures to metabolic pathways (in other words, 
if we switch from biological hardware to biological 
software) the situation changes dramatically, as the 
degree of intercommunication, variability, noise, 
and enzymatic promiscuity present in metabolic 
pathways makes the concept of module much 
more blurred. This has important consequences 
for synthetic biology, since modularity implies 
a much easier design, construction, and reparation 
of a complex system, as it is fractioned in simpler 
parts. If modules do not exist, or they are too 
complexly connected to other modules (the latter 
being the case in biological systems), the goal 
to standardize modules/blocks/pathways becomes 
a huge challenge.
 ■ CONCLUSION
In summary, standardization in biology is an immense 
challenge, due to the complexity of living systems, 
their intrinsic variation and diversity, the promiscuity 
and noise in protein interactions and catalysis, 
Modules are one of the other key concepts of standardization, 
and in biology it is easy to identify anatomical structures 
as such. However, when we enter the field of metabolic 
pathways, this modularity is no longer as well defined. 
And without well-delimited modules, the challenge 












the tendency of biological standards to be context-
dependent, and the absence of bona fide biological 
modules. Solving these technical issues is just the first 
step towards standardization since developing standards 
is, above all, a social process, in which end users 
and policy makers agree in the choice of standards 
and how to use them. As we have seen in this work, 
we are far from having standards in biology today, 
but the partial successes in some cases (e.g., SEVA 
plasmids) and the magnitude of the benefits of having 
biology standardized make the endeavor worthy. 
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